戻る Agenda
Session 5 Track 1 and 3: So You’ve Got Insights, Now What?
Session Chair(s)
Dannis Chang, PharmD
Director, Hematology Medical Information Team Lead
Genentech, Inc., United States
Joshua Corriveau, PharmD, MBA
Global Medical Director
LEO Pharma, United States
Medical Affairs is uniquely positioned to understand the patient and physician barriers at each step, helping to illuminate needs that can then inform strategic and tactical plans across the organization. Collecting information and generating quantitative metrics is the ‘easiest’ part of the insight process. Linking the insight to some relevant strategic action is the hardest part—what trends can we anticipate to better exceed the expectations of our key external and internal stakeholders?
Learning Objective : At the conclusion of this session, participants should be able to:
- Describe how to capture customer insights involving clinical practice dynamics
- Build a cross-functional forum to foster discussion of insights and create clear accountability to implement changes to strategy or new tactics
- Establish common frameworks to consolidate insights across functions to maximize the strategic impact of medical insights
Speaker(s)
Speaker
Richard Ho, PhD, MS
Javelin Bioscience, United States
Co-Founder
Speaker
Robin Winter-Sperry, MD
Scientific Resilience, United States
President
Speaker
Mary Alice Dwyer, PharmD
Synetic Life Sciences, United States
Vice President, US
Speaker
Annette Ogbru, PharmD, MBA
Lundbeck, United States
Director, Field Medical Affairs